Latest Operational Reset News

Page 1 of 8
Cann Group says its balance-sheet repair and cost cuts have created room for growth, with September-quarter revenue and exports jumping. But the medicinal cannabis producer remains loss-making on a normalised basis and is now under pressure to turn improving sales into consistently positive cash flow.
Ada Torres
Ada Torres
18 Nov 2026
Revvity has set out a long-range growth strategy built around AI-enabled scientific discovery, recurring software revenue and specialised diagnostics. The plan includes double-digit adjusted EPS growth, margin expansion and about US$5 billion of capital capacity through 2031, but formal 2027 guidance is still pending.
Ada Torres
Ada Torres
14 Nov 2026
Charter Communications has launched a major operating reset after pro forma revenue, EBITDA and Internet customers declined in the third quarter. The company is targeting US$2 billion in annualised savings, but carries US$108.6 billion of debt after completing its Cox acquisition.
Sophie Babbage
Sophie Babbage
6 Nov 2026
National Australia Bank’s FY2026 profit fell 9.1% to $6.143 billion as higher credit impairment charges and a $1.347 billion software amortisation charge outweighed stronger lending income. The dividend held at 170 cents per share, while capital buffers improved and management flagged a sharper focus on efficiency and risk control.
Victor Sage
Victor Sage
5 Nov 2026
Beam Communications has returned to positive underlying earnings and cash generation after exiting ZOLEO, but the reset comes with a materially smaller revenue base. The satellite communications group expects FY27 operating cashflow to remain positive despite forecasting lower revenue than FY26.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Peak Processing has kept Group EBITDA positive for a second consecutive quarter while reducing operating cash outflow by about 79% to A$317,000. The improvement comes with lower quarterly revenue, A$813,000 of cash and fully drawn debt facilities, leaving execution in the December quarter crucial.
Victor Sage
Victor Sage
30 Oct 2026
Tartana Minerals has accelerated exploration after a shareholder-driven leadership overhaul, but its cash runway is shorter than the time to its next major debt maturity. Assays from Nightflower, copper drilling and regional sampling now carry added significance as the company negotiates refinancing and reviews its stalled copper sulphate operation.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Integral Diagnostics has opened FY27 below expectations, with radiologist and sonographer shortages limiting revenue growth and pushing labour costs ahead of sales. The company expects FY27 revenue growth of 4% to 6% and a full-year operating EBITDA margin of 19.5% to 20.5%, with improvement weighted to the second half.
Ada Torres
Ada Torres
29 Oct 2026
Comvita has moved from NZ$62.4 million of net debt to NZ$0.5 million of net cash in a year, while FY27 first-quarter sales rose 4.6%. The sharper test now is whether its operating reset can convert a stronger balance sheet into durable shareholder returns, with no FY27 dividend expected and board control still contested.
Victor Sage
Victor Sage
28 Oct 2026
Range International sharply reduced its quarterly cash outflow while lifting pallet volumes and building a larger rental fleet. But the next phase still depends on a partly subscribed entitlement offer, external funding and several customer opportunities that remain indicative.
Victor Sage
Victor Sage
27 Oct 2026
Pure Foods Tasmania has reported a deeper FY26 loss, negative cash and a material uncertainty over its ability to continue as a going concern. The company says existing facilities may be insufficient from February 2027, with further equity funding uncommitted and a second bank covenant breach possible.
Victor Sage
Victor Sage
27 Oct 2026
Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.
Victor Sage
Victor Sage
26 Oct 2026

Browse the archive

Full archive